• Subscribe
  • Magazine
  • Past Issues
  • Surveys
  • Industry Statistics
  • About Us
  • Members Only
  • Best Places to Work
    • Recent Quotes
    My Watchlist
    Indicators
    PennEnergy Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Immunic Inc (NQ: IMUX )

    1.470 -0.040 (-2.65%)
    Streaming Delayed Price Updated: 11:22 AM EDT, Sep 3, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Immunic Inc

    < Previous 1 2 3 4 5 6 Next >
    Peek Behind the Curtain: 7 Penny Stocks With Heavy Insider Buying
    While speculative ideas are treacherous, you can possibly reduce your blood pressure with these penny stocks with insider buying. 
    Via InvestorPlace
    Immunic CMO discusses role of clinical trials in biotech development for Clinical Trials Day
    Immunic Inc (NASDAQ:IMUX) chief medical officer Dr Andreas Muehler discusses the importance of clinical trials in the biotech industry to mark Clinical Trials Day on May 20. 
    Via TheNewswire.com
    Immunic CMO discusses role of clinical trials in biotech development for Clinical Trials Day
    Immunic CMO discusses role of clinical trials in biotech development for Clinical Trials Day 
    Via News Direct
    Immunic chief medical officer discusses promising treatments to mark World IBD Day
    Immunic chief medical officer discusses promising treatments to mark World IBD Day 
    Via News Direct
    Immunic chief medical officer discusses promising treatments to mark World IBD Day
    Immunic Inc (NASDAQ:IMUX) chief medical officer Dr Andreas Muehler discusses Inflammatory Bowel Disease (IBD) with Proactive's Stephen Gunnion to mark World IBD Day on May 19. 
    Via TheNewswire.com
    IMUX Stock Earnings: Immunic Misses EPS for Q1 2024
    IMUX stock results show that Immunic missed analyst estimates for earnings per share the first quarter of 2024. 
    Via InvestorPlace
    Immunic's Earnings Outlook
    Via Benzinga
    Immunic: Q3 Earnings Insights
    Via Benzinga
    A Preview Of Immunic's Earnings
    Via Benzinga
    Immunic highlights IMU-856 gastrointestinal candidate to mark International Celiac Day
    Immunic highlights IMU-856 gastrointestinal candidate to mark International Celiac Day 
    Via News Direct
    Immunic highlights IMU-856 gastrointestinal candidate to mark International Celiac Day
    Immunic Inc (NASDAQ:IMUX) chief scientific officer Hella Kohlhof joined Proactive's Stephen Gunnion on International Celiac Day, in the middle of Celiac Disease Awareness Month, to discuss the disease... 
    Via TheNewswire.com
    Immunic CEO Dr Daniel Vitt discusses key Q1 advances and upcoming milestones
    Immunic CEO Dr Daniel Vitt discusses key Q1 advances and upcoming milestones 
    Via News Direct
    Topics Intellectual Property
    Exposures Intellectual Property
    Immunic CEO Dr Daniel Vitt discusses key Q1 advances and upcoming milestones
    Immunic Inc (NASDAQ:IMUX) CEO Dr Daniel Vitt takes Proactive's Stephen Gunnion through the company's first-quarter achievements and upcoming milestones for its clinical pipeline of orally administered,... 
    Via TheNewswire.com
    Topics Intellectual Property
    Exposures Intellectual Property
    Immunic Phase 2 EMPhASIS trial data highlighted in peer-reviewed neurology journal
    Immunic Phase 2 EMPhASIS trial data highlighted in peer-reviewed neurology journal 
    Via News Direct
    Immunic "super excited" about latest PMS trial data
    --News Direct-- 
    Via News Direct
    Immunic Phase 2 EMPhASIS trial data highlighted in peer-reviewed neurology journal
    Immunic Inc (NASDAQ:IMUX) CEO Dr Daniel Vitt joined Proactive's Stephen Gunnion with news of the publication of extended data from the Phase 2 EMPhASIS trial of vidofludimus calcium in... 
    Via TheNewswire.com
    Immunic CMO discusses complexities of multiple sclerosis to mark MS Awareness Month
    --News Direct-- 
    Via News Direct
    Immunic CMO discusses complexities of multiple sclerosis to mark MS Awareness Month
    Immunic Inc (NASDAQ:IMUX) Chief Medical Officer Dr Andreas Muehler discusses the complexities of multiple sclerosis (MS) during an interview with Proactive's Stephen Gunnion to mark MS Awareness Month,... 
    Via TheNewswire.com
    Immunic And 2 Other Stocks Under $2 Insiders Are Buying
    The Dow Jones index closed lower by over 20 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders... 
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    What's Going On With Immunic Stock?
    Immunic, Inc. (NASDAQ: IMUX) shares are roughly flat following strength early Friday after the company announced a three-tranche private placement of up to $240 million. 
    Via Benzinga
    12 Health Care Stocks Moving In Friday's Pre-Market Session
    Via Benzinga
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
    Pre-market stock movers are worth checking on Friday as we lay out all of the biggest stories worth keeping tabs on this morning! 
    Via InvestorPlace
    Immunic CSO hails "great" progress with MS program
    --News Direct-- 
    Via News Direct
    Immunic CSO hails "great" progress with MS program
    Immunic Inc (NASDAQ:IMUX) Chief Scientific Officer Hella Kohlhof speaks to Thomas Warner at the Proactive London after returning from MSMilan2023, the 9th Joint ECTRIMS-ACTRIMS meeting. She shares some... 
    Via TheNewswire.com
    Immunic "super excited" about latest PMS trial data
    Immunic Inc (NASDAQ:IMUX) President and CEO Dr Daniel Vitt speaks to Thomas Warner from Proactive after the biotechnology company announced encouraging interim data from its phase II CALLIPER trial... 
    Via TheNewswire.com
    Why Startek Shares Are Trading Higher By 29%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
    Gainers SuperCom Ltd. (NASDAQ: SPCB) shares jumped 89% to $0.6805, after falling 13% on Monday. 
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's Pre-Market Session
    Via Benzinga
    Multiple Sclerosis Impacts 1M People In US - Immunic Reveals 'Positive' Data From Nerve Disorder Candidate
    Immunic Inc (NASDAQ: IMUX) announced interim data from its phase 2 CALLIPER trial of nuclear receptor-related 1 (Nurr1) activator, vidofludimus calcium (IMU-838), in patients with  
    Via Benzinga
    Why Immunic Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket
    Gainers SuperCom Ltd. (NASDAQ: SPCB) shares rose 78.4% to $0.6425 in pre-market trading, after falling 13% on Monday. 
    Via Benzinga
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
    It's time to dive into the biggest pre-market stock movers with all the most recent news moving shares on Tuesday morning! 
    Via InvestorPlace
    < Previous 1 2 3 4 5 6 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.